Skip to main content
. 2016 Mar 15;11(3):e0150698. doi: 10.1371/journal.pone.0150698

Table 1. Pre-treatment adolescent characteristics.

All (N = 159) PML (N = 83) SFT (N = 76)
M/N SD/% M/N SD/% M/N SD/% Comparison
Gender (N boys) 117 73.6 63 75.9 54 71.1 χ2(1) = .48, ϕ = .06
Age in years 14.4 1.2 14.4 1.2 14.4 1.3 t(157) = .19, d = .00
FSIQ 103.4 11.8 102.5 11.6 104.3 11.9 t(157) = -.97, d = .15
Parental educationa 3.1 0.8 3.2 0.7 3.1 0.8 t(146) = .55, d = .13
N Medication 124 78.0 62 74.7 62 81.6 χ2(1) = 1.09, ϕ = .08
ADHD Subtype χ2(2) = 5.06, ϕ = .18
ADHD-Inattentive 112 70.4 62 74.7 50 65.8
ADHD-Hyperactive/impulsive 8 5.0 6 7.2 2 2.6
ADHD-Combined 39 24.5 15 18.1 24 31.6
Other measures
ADHD symptoms 25.3 9.3 25.6 9.5 25.0 9.2 t(157) = .40, d = .06
Planning problems 28.2 4.4 28.0 4.5 28.4 4.4 t(157) = -.54, d = .09
ODD/CD symptoms 6.6 5.1 6.8 5.3 6.5 5.0 t(157) = .37, d = .06
Depression symptoms 10.0 6.1 10.1 6.5 10.0 5.7 t(157) = .13, d = .02
Anxiety symptoms 25.3 9.3 27.0 19.4 24.1 18.3 t(157) = .99, d = .15
Overall Impairment 31.5 11.5 32.3 11.7 30.6 11.3 t(157) = .93, d = .15

Note: ADHD, Attention Deficit Hyperactivity Disorder; CD, Conduct Disorder; FSIQ, Full Scale IQ; ODD, Oppositional Defiant Disorder; PML, Plan My Life; SFT, Solution Focused Treatment.

a On this variable data are missing. Cramer’s ϕ effect size: .10 is small, .30 is medium, .50 is large; Cohen’s d effect size: 0.2 is small, 0.5 medium, 0.8 large.